XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue - Summary of Revenues Disaggregated by Product Classification and Reportable Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Disaggregation Of Revenue [Line Items]        
Total revenue $ 26,106 $ 34,995 $ 49,109 $ 57,292
Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 13,964 11,783 26,308 21,885
Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 9,844 20,052 17,943 29,386
Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,298 3,160 4,858 6,021
Operating Segments [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 26,106 34,995 49,109 57,292
Operating Segments [Member] | Medical Device [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 18,453 27,907 35,361 44,103
Operating Segments [Member] | Medical Device [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 6,441 5,410 13,229 9,971
Operating Segments [Member] | Medical Device [Member] | Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 8,358 7,474 15,244 15,383
Operating Segments [Member] | Medical Device [Member] | License Fees [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 1,486 12,578 2,699 14,003
Operating Segments [Member] | Medical Device [Member] | Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,168 2,445 4,189 4,746
Operating Segments [Member] | In Vitro Diagnostics [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 7,653 7,088 13,748 13,189
Operating Segments [Member] | In Vitro Diagnostics [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 7,523 6,373 13,079 11,914
Operating Segments [Member] | In Vitro Diagnostics [Member] | Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue $ 130 $ 715 $ 669 $ 1,275